U.S. Markets closed

Novavax Stock Is Rising. Its Long-Delayed Vaccine Is Moving Ahead.

·2 min read
Novavax Stock Is Rising. Its Long-Delayed Vaccine Is Moving Ahead.
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

The company said it completed its submission for authorization to U.K. regulators. It will ask the FDA for emergency-use authorization by year's end.